Index by author

September 01, 1995; Volume 62,Issue 5

  1. Seidner, Douglas L.

    1. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease
      Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
      Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;

      Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

  2. Stoller, James K.

    1. A 47-year-old woman with a swollen leg
      Rochelle Rosian, MD and Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine September 1995, 62 (5) 281-284;

      A self-test featuring a challenging clinical presentation.

Back to top

In this issue